Top Section/Ad
Top Section/Ad
Most recent
Offer came as markets recovered and volatility fell
Abbott Laboratories plundered $20bn as it led a trio of drug companies which printed jumbo bonds as a deluge of supply in the dollar market ensured a red-hot end to the month.
Eight banks provided loan facility to company
More articles/Ad
More articles/Ad
More articles
-
The closing of borders between mainland Europe and the UK has provided a brief glimpse into the chaos that the immediate imposition of trading restrictions between the UK and EU might caused in the event of a no-deal Brexit on December 31. Both sides need to work around the clock to finalise a deal with a generous implementation period to avoid the kind of nightmare scenario that could lead to investors fleeing the UK. -
Gol, Brazil’s largest domestic airline, has priced a $200m six year private placement. This is one of the first deals from a Latin American airliner since the pandemic struck, and comes after a number of peers in the region have fallen into bankruptcy.
-
Equity investors have begun in recent months to allocate capital away from some of the high growth firms which dominated equity capital market supply this year to more cyclical companies that are set to benefit when economies reopen from Covid-19 lockdowns. They are also looking to buy into emerging markets, predicting rising equity valuations in places like Russia and some parts of Latin America.
-
European ABS issuance is closing the year with the lowest volumes since 2009, with the Covid-19 economic turmoil and cheap central bank liquidity having deterred issuers from coming to market.
-
The looming threat of a no deal Brexit, as well as the chaos ensuing from the UK’s new stricter restrictions to combat Covid-19, caused Gilt yields to plunge on Monday morning. Unless EU and UK politicians are able to come to agreement on a trade deal soon, negative rates look almost inevitable.
-
Emerging market bond trading desks were quiet on Monday, as the last business week of the year began with the world reacting to the rapid spread of a new strain of the Sars-Cov-2 virus in the UK. But market participants expect that EM assets cannot remain immune.
